The Ovarian Cancer Opportunity: Overcoming Complexity in Global Studies - Pharmaceutical Technology

Ovarian cancer research is entering a pivotal era characterized by increasing complexity for large, global studies. As sponsors seek to address unmet needs with personalized medicines and innovative immunotherapies, ovarian cancer research is entering a pivotal era characterized by increasing complexity for large, global studies. Each year in the US, more than 21,000 women will receive a new diagnosis of ovarian cancer according to the latest estimates from the American Cancer Society, while more than 12,450 women will die from the disease. First-line treatment is based on cytoreductive surgery, often a complete hysterectomy, followed by platinum-based chemotherapy. However, with most…

Source: Pharmaceutical Technology